CARL
Carlsmed Inc

50
Mkt Cap
$337.73M
Volume
38,938.00
52W High
$17.19
52W Low
$11.55
PE Ratio
-12.70
CARL Fundamentals
Price
$13.03
Prev Close
$12.70
Open
$12.76
50D MA
$13.39
Beta
1.09
Avg. Volume
63,178.16
EPS (Annual)
-$0.9371
P/B
3.17
Rev/Employee
$305,224.72
Loading...
Loading...
News
all
press releases
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery
Carlsmed launches personalized aprevo cervical platform with early cases and new reimbursement support driving momentum in spine surgery.
Zacks·2d ago
News Placeholder
More News
News Placeholder
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery
Carlsmed launches personalized aprevo cervical platform with early cases and new reimbursement support driving momentum in spine surgery.
Zacks·2d ago
News Placeholder
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery
Carlsmed launches personalized aprevo cervical platform with early cases and new reimbursement support driving momentum in spine surgery.
Zacks·2d ago
News Placeholder
CARL Launches Aprevo Cervical Platform for Personalized Spine Surgery
Carlsmed launches personalized aprevo cervical platform with early cases and new reimbursement support driving momentum in spine surgery.
Zacks·2d ago
News Placeholder
Carlsmed (NASDAQ:CARL) Raised to Hold at Wall Street Zen
Wall Street Zen upgraded Carlsmed from a "sell" rating to a "hold" rating in a report on Saturday...
MarketBeat·26d ago
News Placeholder
Truist Financial Reaffirms Buy Rating for Carlsmed (NASDAQ:CARL)
Truist Financial reissued a "buy" rating and issued a $20.00 price objective (up previously from $18.00) on shares of Carlsmed in a research note on Friday...
MarketBeat·1mo ago
News Placeholder
Carlsmed (NASDAQ:CARL) Announces Earnings Results, Beats Expectations By $0.05 EPS
Carlsmed (NASDAQ:CARL - Get Free Report) posted its earnings results on Thursday. The company reported ($0.40) EPS for the quarter, topping the consensus estimate of ($0.45) by $0.05...
MarketBeat·1mo ago
News Placeholder
Carlsmed Stock Down 6% Since IPO But Goldman Bullish And Predicts 35% Upside Potential — Retail Traders Stay Bearish
The company’s July IPO raised $100.5 million but shares have slipped since, closing Friday at $13.58 before edging up in after-hours trade.
Stocktwits·4mo ago

Latest CARL News

View

Advertisement|Remove ads.

Advertisement|Remove ads.